These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 2032024)

  • 1. Management of immune haemolytic disease in the fetus.
    Tannirandorn Y; Rodeck CH
    Blood Rev; 1991 Mar; 5(1):1-14. PubMed ID: 2032024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New approaches in the treatment of haemolytic disease of the fetus.
    Tannirandorn Y; Rodeck CH
    Baillieres Clin Haematol; 1990 Apr; 3(2):289-320. PubMed ID: 2121301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Management of feto-maternal red cell allo-immunizations].
    Bricca P; Guinchard E; Guitton Bliem C
    Transfus Clin Biol; 2011 Apr; 18(2):269-76. PubMed ID: 21397546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of pregnancies complicated by anti-E alloimmunization.
    Joy SD; Rossi KQ; Krugh D; O'Shaughnessy RW
    Obstet Gynecol; 2005 Jan; 105(1):24-8. PubMed ID: 15625137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Blood group immunization: results of treatment of fetal anemia with intra-uterine intravascular blood transfusion in the Netherlands, 1987-1995].
    van Kamp IL; Klumper FJ; Meerman RH; Brand A; Bennebroek Gravenhorst J; Kanhai HH
    Ned Tijdschr Geneeskd; 1999 Dec; 143(50):2527-31. PubMed ID: 10627756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The management of hemolytic disease in the fetus and newborn.
    Bowman J
    Semin Perinatol; 1997 Feb; 21(1):39-44. PubMed ID: 9190032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transfusion support in the management of immune haemolytic disorders.
    Plapp FV; Beck ML
    Clin Haematol; 1984 Feb; 13(1):167-83. PubMed ID: 6327130
    [No Abstract]   [Full Text] [Related]  

  • 8. Current clinical management of anti-Kell alloimmunization in pregnancy.
    Santiago JC; Ramos-Corpas D; Oyonarte S; Montoya F
    Eur J Obstet Gynecol Reprod Biol; 2008 Feb; 136(2):151-4. PubMed ID: 17481801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of anti-Jka alloimmunization.
    Franco A; Rossi K; Krugh D; O'Shaughnessy R
    J Reprod Med; 2009 Mar; 54(3):121-5. PubMed ID: 19370894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Haemolytic disease of the fetus and newborn/HDFN/timing in pregnant women and prophylaxis].
    Kulinska R
    Akush Ginekol (Sofiia); 2014; 53(2):58-63. PubMed ID: 25098112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-U and haemolytic disease of the fetus and newborn.
    Smith G; Knott P; Rissik J; de la Fuente J; Win N
    Br J Obstet Gynaecol; 1998 Dec; 105(12):1318-21. PubMed ID: 9883926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Foetomaternal erythrocyte incompatibilities: from immunohaematologic surveillance of pregnant women to haemolytic disease of the newborn].
    Miquel E; Cavelier B; Bonneau JC; Rouger P
    Transfus Clin Biol; 2005 Feb; 12(1):45-55. PubMed ID: 15814293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prenatal diagnosis and therapy of hemolytic disease of the newborn].
    Fischer K; Poschmann A; Hellwege HH; Kitschke HJ; Carstensen M; Sprotte C; Schreer I
    Monatsschr Kinderheilkd; 1985 Mar; 133(3):167-70. PubMed ID: 4010672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Haemolytic disease of the fetus and newborn.
    de Haas M; Thurik FF; Koelewijn JM; van der Schoot CE
    Vox Sang; 2015 Aug; 109(2):99-113. PubMed ID: 25899660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Erythroblastosis fetalis produced by anti-k.
    Bowman JM; Harman FA; Manning CR; Pollock JM
    Vox Sang; 1989; 56(3):187-9. PubMed ID: 2728396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Fetomaternal alloimmunization: role of cordocentesis].
    Donner C; Kadri R; Heymans O; Lambermont M; Gosselin F; Rodesch F
    Rev Med Brux; 1992 Apr; 13(4):124-8. PubMed ID: 1594825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical consequences of the extremely rare anti-PP1Pk isoantibodies in pregnancy: a case series and review of the literature.
    Di Ciaccio P; Cutts B; Alahakoon TI; Dennington PM; Soo LA; Curnow J
    Vox Sang; 2021 May; 116(5):591-600. PubMed ID: 33326620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hemolytic disease of the fetus and newborn: managing the mother, fetus, and newborn.
    Delaney M; Matthews DC
    Hematology Am Soc Hematol Educ Program; 2015; 2015():146-51. PubMed ID: 26637714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maternal immunity to red cell antigens and fetal transfusion.
    Gibble JW; Ness PM
    Clin Lab Med; 1992 Sep; 12(3):553-76. PubMed ID: 1521427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hemolytic Disease of the Fetus and Newborn: Modern Practice and Future Investigations.
    Hendrickson JE; Delaney M
    Transfus Med Rev; 2016 Oct; 30(4):159-64. PubMed ID: 27397673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.